Corcept Therapeutics reported $103.39M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
Ani Pharmaceuticals ANIP:US $ 73.86M 9.38M
Aurora Cannabis Inc ACB:CN 50.43M 10.15M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bristol Myers Squibb BMY:US $ 11887M 239M
Canopy Growth Corp WEED:CN C$ 110.12M 1.66M
Corcept Therapeutics CORT:US $ 103.39M 9.7M
Depomed DEPO:US $ 36.54M 3.21M
Eleven Biotherapeutics EBIO:US $ 0M 20M
Eli Lilly And LLY:US $ 6488M 1322M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Johnson & Johnson JNJ:US $ 24020M 594M
Knight Therapeutics Inc GUD:CN C$ 63.81M 5.53M
Lannett LCI:US $ 78.36M 8.15M
Lexicon Pharmaceuticals LXRX:US $ 0.04M 0M
Merk MRK:US $ 14593M 1308M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Novartis NOVN:VX SF 13085M 271M
Novartis NVS:US $ 13085M 271M
Pacira Pharmaceuticals PCRX:US $ 169.41M 11.42M
Pfizer PFE:US $ 27742M 2081M
Supernus Pharmaceuticals SUPN:US $ 170.05M 17.55M
Tg Therapeutics TGTX:US $ 0.59M 1.42M